Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 114090-47-0
2. Dtxsid60765688
Molecular Weight | 235.32 g/mol |
---|---|
Molecular Formula | C14H21NO2 |
XLogP3 | 3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 235.157228913 g/mol |
Monoisotopic Mass | 235.157228913 g/mol |
Topological Polar Surface Area | 32.7 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 261 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Phenylephirine Oxazolidine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Phenylephirine Oxazolidine, including repackagers and relabelers. The FDA regulates Phenylephirine Oxazolidine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Phenylephirine Oxazolidine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Phenylephirine Oxazolidine supplier is an individual or a company that provides Phenylephirine Oxazolidine active pharmaceutical ingredient (API) or Phenylephirine Oxazolidine finished formulations upon request. The Phenylephirine Oxazolidine suppliers may include Phenylephirine Oxazolidine API manufacturers, exporters, distributors and traders.
click here to find a list of Phenylephirine Oxazolidine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Phenylephirine Oxazolidine DMF (Drug Master File) is a document detailing the whole manufacturing process of Phenylephirine Oxazolidine active pharmaceutical ingredient (API) in detail. Different forms of Phenylephirine Oxazolidine DMFs exist exist since differing nations have different regulations, such as Phenylephirine Oxazolidine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Phenylephirine Oxazolidine DMF submitted to regulatory agencies in the US is known as a USDMF. Phenylephirine Oxazolidine USDMF includes data on Phenylephirine Oxazolidine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Phenylephirine Oxazolidine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Phenylephirine Oxazolidine suppliers with USDMF on PharmaCompass.
Phenylephirine Oxazolidine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Phenylephirine Oxazolidine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Phenylephirine Oxazolidine GMP manufacturer or Phenylephirine Oxazolidine GMP API supplier for your needs.
A Phenylephirine Oxazolidine CoA (Certificate of Analysis) is a formal document that attests to Phenylephirine Oxazolidine's compliance with Phenylephirine Oxazolidine specifications and serves as a tool for batch-level quality control.
Phenylephirine Oxazolidine CoA mostly includes findings from lab analyses of a specific batch. For each Phenylephirine Oxazolidine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Phenylephirine Oxazolidine may be tested according to a variety of international standards, such as European Pharmacopoeia (Phenylephirine Oxazolidine EP), Phenylephirine Oxazolidine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Phenylephirine Oxazolidine USP).
LOOKING FOR A SUPPLIER?